Cleerly Stock

Heart Disease Diagnosis Solutions

Sign up today and learn more about Cleerly Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Cleerly Stock

Cleerly is a healthcare company whose mission is to create digital care pathways to prevent heart attacks. The company develops a new standard for coronary artery disease by integrating quality clinical science with the latest-generation AI to offer actionable clinical insights to every stakeholder in the heart care pathway. Through these data-driven solutions, the company aims to provide a comprehensive solution for cardiovascular disease evaluation that offers value to the healthcare system and improves heart health for patients at risk of heart attacks.

Cleerly is headquartered in New York, NY, and was founded in 2017. Notable investors include Fidelity Management and Research, Novartis, and T. Rowe Price.


Funding History

April 2020$11.5M
June 2021$28.1M
June 2021$16.8M
February 2022$230M


Chief Executive Officer

James Min

Chief Medical Officer

James Earls


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: